Who We Are - Neurocrine Biosciences is a leading biopharmaceutical company with a simple purpose to relieve suffering for people with great needs. We are dedicated to discovering developing and commercializing life-changing treatments for patients with under-addressed neurological psychiatric endocrine and immunological disorders. The company's diverse portfolio includes FDA-approved treatments for tardive dyskinesia chorea associated with Huntington's disease classic congenital adrenal hyperplasia hyperphagia in Prader-Willi syndrome endometriosis and uterine fibroids as well as a robust pipeline including multiple compounds in mid- to late-phase clinical development across our core therapeutic areas. For more than three decades we have applied our unique insight into neuroscience and the interconnections between brain and body systems to treat complex conditions. We relentlessly pursue medicines to … Sign In to View